Big News: General Electric Company, Dell Inc, Microsoft Corporation, Vertex Pharmaceuticals Incorporated

Publishing & Media

Share Tweet

Big News: General Electric Company, Dell Inc, Microsoft Corporation, Vertex Pharmaceuticals Incorporated

NEW YORK, April 19, 2013 -, one of the leaders in providing investment alerts on U.S. stocks are announcing Investment Highlights on General Electric Company, Dell Inc, Microsoft Corporation, Vertex Pharmaceuticals Incorporated.

General Electric Company(NYSE:GE) shares dropped 3.97% to $21.77. The company, on April 19, said its first-quarter revenue beat Wall Street expectations, assuaging fears of a miss after a lukewarm report on March
U.S. factory activity.

What Should Be The Fair Value Of GE After The Earnings? Find Out Here (OR Just copy and paste the link)

The company said revenue rose slightly to $35 billion, surpassing the $34.51 billion analysts had expected. The company said it earned $3.53 billion, or 34 cents per share, in the quarter, compared with $3.03 billion, or 29 cents per share, a year earlier. Adjusted profit was 35 cents per share, matching analysts' average forecast.

Dell Inc.(NASDAQ:DELL) shares declined 3.52% to $13.46. The company, on April 18, announced SonicWALL Hosted Email Security 2.0, a cloud-based service providing advanced, multi-layered email threat protection backed by world-class 24/7 online and phone support.

How Should Investors react To Today’s News? Find Out Here (OR Just copy and paste the link)

Additionally, Dell SecureWorks on April 18 announced a reseller agreement with Reliance Globalcom, a Vanco Group company which provides integrated telecommunications services worldwide. Reliance will be working with Dell SecureWorks to deliver Managed Security Services (MSS) to its customers, offering them one solution to meet all their security and networking needs.

Microsoft Corporation (NASDAQ:MSFT) shares gained 4.06% to $29.95. The company on April 18 reported a
fiscal third-quarter profit of $6.06 billion, or 72 cents a share, on revenue of $20.5 billion, compared with earnings of $5.1 billion, or 61 cents a share, on $17.4 billion in sales in the year-ago period. Analysts had forecasted
Microsoft to earn 68 cents a share on $20.53 billion in revenue.

Has MSFT Reached The Bottom And Ready To Move Up? Get Free Trend Analysis Here (OR Just copy and paste the link)

Additionally, Jefferies Group analysts cut their earnings per share (EPS) forecast for shares of Microsoft in a research note issued to investors on April 16. The firm currently has a hold rating and a $31.00 target
price on the stock.

Moreover, the company on April 17 has announced that it is ending support for the Windows XP operating system on April 8, 2014. Germany's Federal Office for Information Security (BSI) advises XP users to update to a newer version of Windows or an alternative like Linux by that date at the latest.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares soared 56.33% to $82.69. The company on April 18 said data from a mid-stage trial showed significant improvements in lung function among adults with the
most common type of the cystic fibrosis, validating the company's research strategy on the disease.

Is VRTX Still a Buy After Today’s gap Up? Get Free Report Here (OR Just copy and paste the link)

The drug, called VX-661, is still years away from coming to market; however, its results give confidence about another cystic fibrosis drug, VX-809, that is similar in function and is much closer to FDA approval.

About is a subscription-based investment newsletter that provides regular coverage, analysis, and commentary on Nasdaq, Pink Sheets and OTCBB Stocks.  Subscribers receive intra-day stock analysis and commentary, as well as access to our regular Special Reports, and Trading Tools.

Disclaimer is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. is a wholly owned entity of a financial public relations firm.  We have not been compensated by any of the companies listed in this news release.
1419 Westwood Blvd Los
Angeles, CA
[email protected]